Dark Mode
Brazil National Medicine Price List
Data Science and Analytics
Tags and Keywords
Trusted By
"No reviews yet"
Free
About
Information is provided detailing over 50,000 medicines and their corresponding prices in Brazil. Given that pharmaceuticals are a fundamental element of any health system globally, this collection offers essential regulatory insight. The data was officially released by the Brazilian government, providing pricing specifics for 53,437 distinct medicines, categorised by product type and various regulatory characteristics.
Columns
The data file contains 13 columns, detailing specific product and regulatory information:
- company_id: The unique identifier for the company, also known as CNPJ in Brazil.
- company_name: The full name of the manufacturing company.
- medicine_id: A unique identifier assigned to the specific medicine.
- product_name: The commercial name of the product.
- presentation_description: Additional descriptive text accompanying the product.
- cas_number: The Chemical Abstract Service (CAS) international identifier.
- substance_name: The name of the primary active substance.
- product_type: A numerical code indicating the type of product, such as Generic, Patent, Reference, Similar, New, Specific, Biological, Dinamized, Fitotherapeutic, radiopharmaceutical, or New biological.
- tax_criteria: Details concerning the tax criteria applied to the product.
- hospital_exclusive: Indicates whether the medicine is restricted to hospital procurement.
- government_discount: Notes if a mandatory discount applies when selling to the government.
- tax_imunity: Specifies if the product benefits from any form of tax immunity.
- max_price: The maximum allowed price dictated for manufacturers and distributors.
Distribution
This resource is available as a single CSV file named
medicine_prices_brazil.csv, with a file size of 8.68 MB. The data structure includes 13 distinct columns, encompassing pricing details for 53,437 total records. The data is available as a snapshot, with the expected update frequency listed as 'Never'.Usage
This data product is ideally suited for research into pharmaceutical pricing economics and policy analysis. It can be used to monitor maximum legal prices, study the market penetration of different product types (e.g., generics versus reference medicines), and analyse the regulatory impacts of tax criteria and mandated government discounts within the Brazilian healthcare market. It is valuable for understanding the cost component of essential medicines in the region.
Coverage
The scope of the data is strictly limited to Brazil. It covers price and regulatory information for over 53,000 distinct pharmaceuticals. The content includes specific details regarding company identification, product composition, product classification, and tax/regulatory status, including notes on hospital exclusivity and government sales discounts.
License
CC0: Public Domain
Who Can Use It
Intended users include:
- Researchers and Academics: For economic modelling of pharmaceutical markets and health policy studies.
- Policy Analysts: To evaluate the impact and effectiveness of maximum pricing regulations set by the government.
- Healthcare Industry Stakeholders: For market intelligence regarding pricing ceilings and competitive analysis across product types (e.g., generic vs. patent).
- Data Journalists: To report on drug affordability and government price transparency in the health sector.
Dataset Name Suggestions
- Brazilian Pharmaceutical Maximum Prices (ANVISA)
- Brazil National Medicine Price List
- Regulatory Prices of Pharmaceuticals in Brazil
Attributes
Original Data Source: Brazil National Medicine Price List
QUALITYLoading...